-transparent.png){kind=logo}
In order to establish whether nitric oxide (NO) participates in the regulation of thyroid stimulating hormone (TSH) secretion in humans, seven normal men were treated with a placebo (normal saline) or the NO synthase inhibitor L-NAME, given at doses (40 micrograms kg-1 injected plus 50 micrograms kg-1 infused i.v.) previously found to be unable to change blood pressure. Experiments were carried out either in basal conditions or during stimulation of TSH secretion with an i.v. injection of 200 micrograms thyrotropin releasing hormone (TRH) or 10 mg of the dopaminergic antagonist metoclopramide (MCP). Administration of L-NAME did not change the basal secretion of TSH or the TSH response to MCP, but significantly reduced the TSH increase induced by TRH. These data fail to provide evidence of NO involvement in regulation of basal TSH secretion. NO also appears to be without effects on the dopaminergic control of TSH secretion. In contrast, the inhibitory effect of L-NAME on TRH-induced TSH secretion suggests the mediation by NO of the TSH-releasing action of TRH.
V Coiro, and
R Volpi, and
P Chiodera
October 1996,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
V Coiro, and
R Volpi, and
P Chiodera
January 1992,
Endokrynologia Polska,
V Coiro, and
R Volpi, and
P Chiodera
December 1982,
Clinical endocrinology,
V Coiro, and
R Volpi, and
P Chiodera
May 1988,
Nihon Naibunpi Gakkai zasshi,
V Coiro, and
R Volpi, and
P Chiodera
September 1984,
Acta endocrinologica,
V Coiro, and
R Volpi, and
P Chiodera
February 1981,
Metabolism: clinical and experimental,
V Coiro, and
R Volpi, and
P Chiodera
June 1997,
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society,
V Coiro, and
R Volpi, and
P Chiodera
May 1984,
Experimental and clinical endocrinology,
V Coiro, and
R Volpi, and
P Chiodera
January 2006,
Hormone research,
V Coiro, and
R Volpi, and
P Chiodera
January 1996,
Journal of neurosurgery,
